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Cancer is one of the most common devastating disease affecting millions of people per 
year. Cancer has been estimated as the second leading cause of death in humans. So there 
has been an intense search on various biological sources to develop a novel anti-cancer drug 
to combat this disease. Plants have proved to be an important natural source of anti-cancer 
therapy for several years. About 30 plant derived compounds have been isolated so far and 
are currently under clinical trials. These anti-cancer compounds have been found to be 
clinically active against various types of cancer cells. Further research in this area may lead 
to better treatment of cancer. 
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Importance of plant secondary metabolites 
Plant secondary metabolites have 
proved to be an excellent reservoir of new 
medical compounds. Many anti-cancer 
agents have been isolated from various plant 
sources like Catharanthus roseus, Podophyllum 
species, Taxus brevifolia, Camptotheca 
acuminate, Betula alba, Cephalotaxus species, 
Erythroxylum pervillei, Curcuma longa, 
Ipomoeca batatas, Centaurea schischkinii and 
many others. Scientists are still attempting to 
explore the bioavailability of anti-cancerous 
compounds in unexplored plant species. 
Anti-cancerous drugs under clinical trials 
There are four major structural 
classifications of plant-derived anti-
cancerous compounds viz., Vinca alkaloids, 
Epipodophyllotoxin lignans, Taxane 
diterpenoids and Camptothecin quinoline 
alkaloid derivatives. Different anti-cancer 
compounds that have been identified and 
reported by scientists have been reviewed 
under. 
1. Vinca alkaloids 
Vinca alkaloids belong to an 
important class of anti-cancer drugs. The 
mechanism of action of Vinca alkaloids is 
that they inhibit the cell proliferation by 
affecting the microtubular dynamics during 
mitosis, and this causes a characteristic block 
during mitosis leading to apoptosis. Certain 
semi-synthetic analogues have been 
developed to increase the therapeutic index. 
Vinblastine (VLB) and Vincristine 
(VCR) are the two major naturally occurring 
active compounds obtained from the 
Madagascar periwinkle, Catharanthus roseus 
G. Don. (Apocynaceae). These compounds 
reported potential activity against 
lymphocytic leukemia in mice. Vinorelbine 
(VRLB) and Vindesine (VDS) are the two 
semi synthetic analogs obtained from the 
active compounds. They showed potential 
activity against leukemia’s, lymphomas, 
advanced testicular cancer, breast cancer, 
lung cancer and Kaposi’s sarcoma when 
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treated in combination with other 
chemotherapeutic drugs (Cragg and 
Newman, 2005). Vinflunine, a bifluorinated 
derivative of vinorelbine exhibits a superior 
anti-tumor activity compared to other vinca 
alkaloids. This novel Vinca alkaloid is 
currently under Phase II clinical trials. Both 
Vinflunine and Vinorelbine exhibits reduced 
toxicity in animal models (Okouneva et al., 
2003; Simeons et al., 2008). 
2. Podophyllotoxin 
Podophyllotoxin is obtained from the roots of 
Podophyllum species, namely, Podophyllum 
peltatum Linnaeus and Podophyllum emodi 
Wallich. This was isolated in 1880s, and their 
structure was elucidated in 1950s. 
Epipodophyllotoxin is an isomer of 
podophyllotoxin. The two clinically 
important semi-synthetic analogs generated 
from Epipodophyllotoxin are Etoposide and 
Teniposide which were found very potential 
in treating lymphomas, bronchial and 
testicular cancers (Shoeb, 2006). 
3. Taxanes 
Paclitaxel (Taxol®) is obtained from the bark 
of the Pacific Yew, Taxus brevifolia Nutt. 
(Taxaceae). Their structure was first 
identified in the year 1971 and they entered 
the market since 1990s. Another species, 
Taxus baccata, an Indian Ayurvedic medicine 
have also been in use for cancer therapy 
(Kingston, 2007). Paclitaxel was found poorly 
water-soluble and toxic, hence, a water-
soluble compound, Docetaxel was derived. 
Docetaxel (Taxotere®), a semi-synthetic 
derivative of paclitaxel was found more 
effective. Docetaxel can be used in patients 
who are resistant to paclitaxel. Both docetaxel 
and paclitaxel are used as first- and second- 
line treatment in patients suffering from 
metastatic cancer, breast cancer and ovarian 
cancer. These drugs are also found active 
against lung cancer, prostate cancer and also 
lymphoid malignancies. The mechanism of 
action is that these active agents bind to the 
polymerized microtubules which prevent the 
normal mitosis to occur and thus they are 
called anti-mitotic drugs (Hait et al., 2007). 
4. Camptothecin (CPT) 
Camptothecin is a cytotoxic alkaloid isolated 
mainly from the bark and stem of the 
Chinese ornamental tree, Camptotheca 
acuminate. It showed poor solubility and 
severe toxicity, and, because of this reason, 
certain analogues of CPT were synthesized to 
overcome these disadvantages. They are 
topotecan, irinotecan (CPT-11), 9-
aminocamptothecin (9-AC), lurtotecan and 
rubitecan. These analogs work by inhibiting 
DNA Topoisomerase I which plays a major 
role in various DNA functions like 
replication and transcription. It is made up of 
a pentacyclic ring structure which contains a 
pyrrole (3, 4 β) quinoline moiety (Srivastava 
et al., 2005). The camptothecin molecule has 
an S-configured lactone form and a 
carboxylate form which is responsible for the 
anti-cancer activity. 
Topotecan is found clinically effective in 
patients with epithelial ovarian cancer and 
small cell lung cancer as a second-line 
treatment (Creemers et al., 1996). Irinotecan 
acts as first- and second-line treatment for 
metastatic colorectal cancer (Fuchs et al., 
2006). DX-8951f (Exatecan) is yet another new 
camptothecin (CPT) derivative which 
demonstrated potential anti-tumor activity 
against various tumors both in-vitro and in-
vivo (Mineko et al., 2000). This synthetic 
analog seems to have better aqueous 
solubility, tumor efficiency and lesser toxic 
effects compared to camptothecin and other 
derivatives (Reichardt et al., 2007). SN-38 (7-
ethyl-10-hydroxycamptothecin), an active 
metabolite of CPT-11 is found to show high 
cytotoxic activity as compared to CPT-11. 
Due to the poor solubility of this 
topoisomerase I inhibitor, it is now designed 
as a liposome-based formulation. This LE-
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SN-38 shows increased cytotoxic effects in 
various cancer cell lines (Zhang et al., 2004). 
CZ-48 acts as effective anti-cancer agent, with 
not much toxicity effects in mice. Research is 
still undergoing for human clinical trials also 
(Cao et al., 2009). 
5. Berbamine 
Berbamine, a bisbenzylisoquinoline alkaloid 
was isolated from the Chinese herb named 
Berberis amurensis. It was reported that 
Gleevec was responsible for bcr/abl tyrosine 
kinase inhibition and therefore used in the 
treatment of chronic myeloid leukemia. But 
few patients developed resistance against 
this drug. It was found that berbamine 
effectively causes cell apoptosis of both 
Gleevec sensitive and resistant Ph+ chronic 
myeloid leukemia cells. They work by 
inducing caspase-3-dependent apoptosis of 
leukemic NB4 cells by the survivin-mediated 
pathway (Xie et al., 2009; Xu et al. 2006). 
6. Berberine 
Berberine, an isoquinoline plant alkaloid is 
obtained from different plant species 
including Hvdrastis Canadensis L., 
(Ranuncufaceae), Berberineeris species 
(Berberidaceae) and Arcungelisia flaw 
(Menispermaceae). They showed anti-tumor 
activity both in-vivo and in-vitro report show 
that berberine has found effective against 
osteosarcoma, lung, liver, prostate and breast 
cancer (Wang et al., 2011; Patil et al., 2010). 
7. Beta-lapachone 
Beta-lapachone (3, 4-dihydro-2, 2-dimethyl-
2H-naphthol [1, 2-b] pyran-5, 6-dione), a 
water-insoluble orthonapthoquinone 
compound, was obtained from the 
heartwood of South American Lapacho tree 
(Tabebuia avellanedae) (Li et al., 2000). This 
compound has a broad spectrum of 
antineoplastic activity against breast cancer, 
prostate cancer, lung cancer, pancreatic 
cancer and also in promyelocytic leukemic 
cells. They work by inhibiting Topoisomerase 
I and II (De Almeida, 2009). But this drug is 
found to have poor solubility, systemic 
toxicity and non-specific distribution. So, 
gold nanoparticles are being used as a carrier 
in delivering the drug in the nano form to 
enhance the radiotherapeutic efficiency 
(Jeong et al., 2009). 
8. Betulinic acid 
Betulinic acid (3β, hydroxy-lup-20(29)-en-28-
oic acid), a lupine class type, pentacyclic 
triterpene compound is obtained naturally 
from various plant species. This compound is 
obtained in good amounts from the bark of 
many trees, including white-barked birch 
trees (Betula alba). The mechanism of action of 
betulinic acid is that they trigger the 
mitochondrial pathway of apoptosis which 
causes cancer cell death. Thus this compound 
exhibits potent anti-cancer activity in humans 
(Fulda, 2008). 
9. Bruceatin 
Bruceantin, a plant derivative exhibits anti-
tumor activity. This anti-tumor compound 
work by irreversible inhibition of protein 
synthesis in HeLa cells, rabbit reticulocytes, 
and reticulocyte lysates. It is seen that 
bruceantin exhibits secondary effect on the 
synthesis of DNA (Liaoo et al., 1976). 
10. Colchicine 
Colchicine is a plant secondary metabolite 
extracted from Colchicum autumnale and 
Gloriosa superba L. It causes mitotic arrest 
during cell cycle and thus they are 
considered as potent anti-mitotic drug both 
in-vitro and in-vivo. Due to severe toxic 
effects, certain derivatives of colchicine were 
synthesized namely, 3-demethyl colchicine, 
colchicoside, thiocolchicocide which showed 
improved activity against certain leukemic 
cells and solid tumors. Research is still 
undergone in the area of anti-cancer therapy 
(Dubey et al., 2008). 
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11. Combretastatin A-4 
Combretastatin A-4 is a naturally occurring 
stilbene compound obtained from the South 
African bush willow tree, Combretum caffrum 
Kuntze. This vascular targeting agent 
disrupts the tubulin structure and the change 
in morphology of endothelial cells causes 
deprivation of nutrients to tumor cells by 
impeding the blood flow through capillaries. 
Due to its poor solubility, a water-soluble 
prodrug called Combretastatin A-4 disodium 
phosphate has been formulated for 
experimental purpose which is currently 
under phase II clinical trials (Thomson et al., 
2006; Ley et al., 2007). 
12. Cucurbitacin 
Cucurbitacin, a tetracyclic triterpenoid 
compound is predominantly obtained from 
the Cucurbitaceae plants. They possess 
antiproliferative behavior against various 
cancer cell lines. Reports show that 
Cucurbitacin- I and B selectively inhibit both 
signal transducer/Janus Kinase 2 (JAK2) 
activity and activator of transcription 3 
(STAT3) pathways. STAT3 is activated in 
many cancer cell types like prostate cancer, 
breast cancer and also carcinoma of the head, 
neck and nasopharynx. Reports show that 
inhibition of this oncogenic signaling 
pathway, STAT3, causes tumor cell growth 
inhibition and leads to apoptosis of cancer 
cells. Polymeric miscelles are used in 
delivering this compound because of its 
water insolubility and non-specific toxicity 
(Molavi et al., 2008; Bernard and Olayinka et 
al., 2010). 
13. Curcumin 
Curcumin (diferuloylmethane), a 
polyphenolic compound is isolated from the 
Indian plant spices, Curcuma longa 
(commonly called turmeric), now finds its 
application as potential anti-cancer 
compound.  About 3–5% of this yellow 
pigment of turmeric contains curcuminoids. 
Curcumin is involved in modulating the cell 
cycle pathway and induces apoptosis of 
various cancer cells. But the exact mechanism 
of action is yet to be studied clearly. Phase 
I/II trials are ongoing on the effects of 
curcumin on colorectal cancer, multiple 
myeloma and pancreatic cancer. Curcumin 
used at a high dosage level is reported to be 
safe by phase I clinical trials (Sa et al., 2010; 
Goel et al., 2008). 
14. Daphnoretin 
Daphnoretin, a bis-coumarin derivative, 
extracted in good amounts from the root bark 
of Wikstroemia indica (Thymelaeaceae) was 
found to have good anti-cancer activity (Lu et 
al., 2011). Daphnoretin causes suppression of 
protein and DNA synthesis in Ehrlich ascites 
carcinomas. It is also seen to suppress the 
hepatitis B surface antigen expression on 
human hepatoma Hep3B cells (Diogo et al., 
2009). 
15. Diadzein and Genistein 
Diadzein (4', 7- Dihydroxyisoflavone) and 
Genistein (4', 5, 7-Trihydroxyisoflavone) are 
the two aglycones present abundantly in the 
Soy Isoflavones. Major sources include 
important legumes like lupine (Lupinus 
spp.), fava bean, (Vicia faba), soybeans 
(Glycine max), kudzu (Pueraria lobata), and 
psoralea (Psoralea corylifolia) (Kaufman et 
al., 1997). These phytochemicals work by 
inhibiting 3A4-mediated metabolism. 
Reports show that they are capable of 
inhibiting oxidative metabolism also (Moon 
et al., 2006). Genistein is found to inhibit cell 
proliferation in both ovarian and breast 
cancers. They also inhibit chemically induced 
cancers in stomach, bladder, lung, prostate, 
colon and blood (Dixon and Ferreira et al., 
2002). 
16. Ellipticine 
A plant alkaloid, Ellipticine (5, 11-dimethyl-
6H-pyrido [4, 3-b] carbazole) and its 
derivatives were isolated from Apocynaceae 
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plant species (eg. Ochrosia borbonica, Excavatia 
coccinea, Ochrosia elliptica). They exhibit 
significant anti-tumor properties against 
various cancer cell types. The primary 
function of this drug is that it intercalates 
with DNA and also causes inhibition of 
Topoisomerase II activity. It is also reported 
that this drug, inhibits cell growth and causes 
apoptosis of human hepatocellular carcinoma 
HepG2 cells (Kao et al., 2006). 
 
Table 1. List of plant derivatives used in cancer therapy 
S. 
No 
Semisynthetic 
analogs of 
plant 
derivatives 
Species and 
Genus name 
Experiments on various 
cancer cells 
Mechanism of action Reference 
1 Vindesine and 
Vinorelbine  
 
Catharanthus 
roseus 
 Leukemias, lymphomas, 
advanced testicular cancer, 
breast cancer, lung cancer 
and Kaposi’s sarcoma. 
mitotic block Cragg and 
Newman, 2005 
2 Vinflunine Catharanthus 
roseus 
Reduced toxicity in animal 
models 
mitotic block Okouneva et al., 
2003; Simeons et 
al., 2008 
3 Etoposide and 
Teniposide 
Podophyllum 
peltatum and 
Podophyllum 
emodi 
Lymphomas, bronchial 
and testicular cancers. 
- Shoeb, 2006 
4 Taxol® 
 
Taxus brevifolia 
Nutt, Taxus 
baccata 
Metastatic, breast, ovarian, 
lung, prostate cancer and 
lymphoid malignancies 
Anti-mitotic Kingston, 2007 
5 Taxotere® Taxus brevifolia 
Nutt, Taxus 
baccata 
Used in patients resistant 
to Paclitaxel 
Anti-mitotic Hait et al., 2007 
6 Topotecan Camptotheca 
acuminate 
Epithelial ovarian cancer 
and small cell lung cancer 
DNA topoisomerase I 
inhibition 
Creemers et al., 
1996 
7 Irinotecan Camptotheca 
acuminate 
Metastatic and colorectal 
cancer 
DNA topoisomerase I 
inhibition 
Fuchs et al., 2006 
8 Exatecan Camptotheca 
acuminate 
Potential anti-tumor 
activity both in vitro and in 
vivo 
DNA topoisomerase I 
inhibition 
Mineko et al., 
2000 
9 LE-SN-38 Camptotheca 
acuminate 
Various cancer cell lines DNA topoisomerase I 
inhibition 
Zhang et al., 2004 
10 Berbamine Berberis 
amarensis 
Chronic myeloid leukemia Caspase-3-dependent 
apoptosis 
Xie et al., 2009; Xu 
et al., 2006 
11 Berberine Hvdrastis 
canadensis L., 
Berberineeris sp& 
Arcungelisia flaw 
Osteosarcoma, lung, liver, 
prostate and breast cancer 
Not known Wang et al., 2011; 
Patil et al., 2010 
12 Beta-
lapachone 
Tabebuia 
avellanedae 
breast cancer, prostate 
cancer, lung cancer, 
pancreatic cancer and 
promyelocytic leukemia. 
Inhibition of 
topoisomerase I and 
II 
Li et al., 2000; De 
Almeida, 2009 
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13 Betulinic acid Betula alba Exhibits anti-cancer 
activity in humans 
Triggers 
mitochondrial 
pathway of apoptosis 
Fulda, 2008 
14 Colchicine Colchicum 
autumnale and 
Gloriosa superba 
L. 
Leukemic and solid tumors Anti-mitotic Dubey et al., 2008 
15 Combretastati
n A-4 
Combretum 
caffrum Kuntze 
Phase II clinical trials Tubulin structure 
disruption 
Thomson et al., 
2006; Ley et al., 
2007 
16 Cucurbitacin Cucurbitaceae 
species 
Various cancer cell lines Inhibits signal 
transducer/JAK 2 
activity and activates 
STAT3 pathway 
Molavi et al., 
2008; Bernard and 
Olayinka et al., 
2010 
17 Curcumin Curcuma longa colorectal cancer, multiple 
myeloma and pancreatic 
cancer. 
Exact mechanism of 
action is still 
unknown 
Sa et al., 2010; 
Goel et al., 2008 
18 Daphnoretin Wikstroemia 
indica 
a) Ehrlich ascites 
carcinomas and  
b) human hepatoma 
Hep3B cells. 
a) suppression of 
protein and DNA 
synthesis 
b) suppresses 
Hepatitis B surface 
antigen expression 
Lu et al. 2011; 
Diogo et al., 2009 
19 Diadzein and 
Genistein 
Lupinus species, 
Vicia faba, 
Glycine max, 
Psoralea 
corylifolia 
Genistein inhibits ovarian 
and breast cancers and also 
chemically induced cancers 
of stomach, bladder, lung, 
prostate, colon and blood. 
Inhibits 3A 4-
mediated metabolism 
and oxidative 
metabolism 
Kaufman et al., 
1997; Moon et al., 
2006; Dixon and 
Ferreira et al., 
2002 
20 Ellipticine Ochrosia 
borbonica, 
Excavatia 
coccinea, 
Ochrosia elliptica 
Various cancer cell types DNA intercalation 
and inhibition of 
topoisomerase II 
Kao et al., 2006 
21 Emodin Rhizome of 
rhubarb 
lung, liver, ovarian and 
blood cancer 
Apoptosis of cancer 
cells by several 
pathways 
Huang et al., 2009 
22 Flavopiridol Amoora rohituka 
and Dysoxylum 
binectariferum 
colorectal, non-small cell 
lung cancer, renal cell 
carcinoma, non-Hodgkin’s 
lymphoma, chronic 
lymphocytic leukemia, and 
also solid tumors 
Inhibits cell cycle 
progression at G1 or 
G2 phase 
Mans et al., 2000 
23 Harringtonine 
and 
Homoharring-
tonine 
Cephalotaxus 
harrintonia, C. 
hainanensis and 
C. qinensis 
Acute myeloid leukemia 
and chronic myeloid 
leukemia. 
Inhibition of protein 
synthesis and chain 
elongation during 
translation 
Cragg and 
Newman, 2005; 
Efferth et al., 2007 
24 Indirubin Chinese herb, 
Danggui 
Longhui Wan 
Chronic myeloid leukemia Inhibits cyclin-
dependent kinases 
Nam et al., 2005 
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25 Ingenol 3-o-
angelate 
Euphorbia peplus 
L. 
actinic keratosis and basal 
cell carcinoma 
Causes necrosis of 
tumor by the 
activation of PKC 
Hampson et al., 
2005 
26 4-Ipomeanol Ipomoeca batatas Lung specific cancer in 
animal models 
cytochrome P-450-
mediated conversion 
into DNA-binding 
metabolites 
Ancuceanu and 
Istudor, 2004 
27 Irisquinone Iridaceaelatea 
pallasii and Iris 
kumaoensis 
Good activity in 
transplantable rodent 
tumors 
Acts as a 
chemosensitizer 
Hazra et al., 2004 
28 Phenoxodiol 
 
 
plant isoflavone, 
genistein 
 
Ovarian, prostate and 
cervical cancer 
 
inhibit plasma 
membrane electron 
transport and cell 
proliferation  
Herst et al., 2009 
 
 
 
29 PandimexTM saponins of 
ginseng 
Advanced cancers of 
breast, colon-rectum, lung, 
pancreas and solid tumors 
Cell cycle arrest and 
acts as P-glycoprotein 
blocker 
Pan et al., 2010 
 
30 Perillyl alcohol Many plant 
species like 
mints, cherries, 
lavenders and 
many others 
Non small cell lung cancer, 
prostate cancer, colon 
cancer and breast cancer. 
Exact mechanism is 
yet to be identified 
Pan et al., 2010; 
Bardona et al., 
2002; Yeruva et 
al., 2007 
31 Pervilleines Erythroxylum 
pervillei 
Yet to be done Inhibitors of P-
glycoprotein 
Mi et al., 2001; Mi 
et al., 2002; Mi et 
al., 2003 
32 Salvicine Salvia prionitis 
Hance  
Malignant tumors Inhibition of 
topoisomerase II 
Deng et al., 2011 
33 Schischkinnin 
 
 
Centaurea 
schischkinii 
 
Colon cancer lines in vitro 
 
 
Not known Shoeb et al., 2005 
 
34 Montamine 
 
Centaurea 
Montana 
CaCo2 colon cancer cell 
line in vitro 
Not known Shoeb et al., 2006 
35 Silvestrol Aglaia foveolata 
Panell 
Prostate, breast and lung 
cancers. 
apoptosome/mitocho
ndrial pathway was 
involved in triggering 
extrinsic pathway of 
programmed cell 
death of tumor cells 
Kinghom et al., 
2009; Kim et al., 
2007 
36 PG490-88 Tripterygium  
wilfordii Hook F 
Prostate  cancer Enhances the anti-
tumor effects of 
cytotoxic and 
chemotherapeutic 
agents, thereby 
induces apoptosis.  
Liu, 2011 
      
17. Emodin 
Emodin (1, 3, 8-trihydroxy-6-methyl-
anthraquinone) is one of the active 
component isolated from the rhizome of 
rhubarb. Rhubarb is used as a traditional 
Chinese medicine for treating various 
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diseases. This anthraquinone compound 
causes apoptosis in many types of cancers 
including lung cancer, liver cancer, ovarian 
cancer and blood cancer by several pathways 
(Huang et al., 2009). 
18. Flavopiridol 
Flavopiridol, a semisynthetic flavone 
derivative of the plant alkaloid rohitukine is 
isolated from the leaves and stems of Amoora 
rohituka and also from Dysoxylum 
binectariferum (Maliaceae). This anti-cancer 
agent works by inhibiting cell cycle 
progression at G1 or G2 phase by interfering 
with the phophorylation activity of cyclin-
dependent kinases. Flavopiridol is under 
phase I trials for treating solid tumors and is 
also undergoing phase II clinical trials for the 
treatment of wide range cancers like 
colorectal, non-small cell lung, and renal cell 
carcinoma, non-Hodgkin’s lymphoma and 
also chronic lymphocytic leukemia (Mans et 
al., 2000). It is also found effective against 
rhabdoid tumors, a pediatric malignancy 
(Smith et al., 2008). 
19. Harringtonine and Homoharringtonine 
Harringtonine and Homoharringtonine are 
the two alkaloid esters of cephalotaxine. They 
were originally used as the traditional 
Chinese medicine to cure cancer. These 
compounds were isolated from the evergreen 
coniferous shrubs of Cephalotaxus species, 
like C. harrintonia, C. hainanensis and C. 
qinensis. Homoharringtonine is found 
effective against various leukaemic cells. 
They work by inhibiting protein synthesis 
and also cause inhibition of chain elongation 
during translation. It is found that, a mixture 
of harringtonine and homoharringtonine can 
be used in treating both acute myeloid 
leukemia (AML) and chronic myeloid 
leukemia (CML) (Cragg and Newman, 2005; 
Efferth et al., 2007). 
 
20. Indirubin and Meisoindigo 
Indirubin is an important active compound 
of the traditional Chinese herbal medicine, 
Danggui Longhui Wan. Indirubin works by 
inhibiting cyclin-dependent kinases, which 
causes cell cycle arrest and also inhibits the 
proliferation of tumor cells. This active agent 
was used in the treatment of chronic myeloid 
leukemia (Nam et al., 2005). But due to 
various disadvantages of indirubin like poor 
solubility and absorption, methylisoindigotin 
(abbreviated as meisoindigo) has been 
derived. Meisoindigo, a second generation 
derivative of indirubin, showed good 
efficiency with lower toxicity effects. Their 
mode of action is still not fully understood. 
Yet it has been reported that they cause 
inhibition of DNA and RNA biosynthesis in 
W256 cells and also inhibits the microtubular 
assembly. This anti-cancer agent is clinically 
effective against chronic myeloid leukemia 
(CML) (Liu et al., 1996). 
21. Ingenol 3-o-angelate 
Ingenol 3-angelate (PEP-005), a derivative of 
ingenol was originally obtained from the 
plant species, Euphorbia peplus L. This 
diterpene ester initially causes necrosis of 
tumor cells by the activation of PKC leading 
to tumor cell death. This compound is under 
phase II clinical trials for treating actinic 
keratosis and basal cell carcinoma (Hampson 
et al., 2005). 
22. 4-Ipomeanol 
4-Ipomeanol is a pneumotoxic furan 
derivative. It is obtained from the sweet 
potato Ipomoeca batatas (Convolvulaceae) 
which has been affected by Fusarium solani. 
The mechanism of action is that it causes 
cytochrome P-450-mediated conversion into 
DNA-binding metabolites. This 
monoterpene, cytotoxic agent showed 
promising result for lung-specific cancer in 
pre-clinical studies with animal models. But, 
unexpectedly, poor results were obtained in a 
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clinical setting (Ancuceanu and Istudor, 
2004). 
23. Irisquinone 
Irisquinone, a benzoquinone with anti-tumor 
activity is obtained from plant species like 
Iridaceaelatea pallasii and Iris kumaoensis 
(Iridaceae). Irisquinone showed good activity 
against transplantable rodent tumors and 
also acts as a chemosensitizer (Hazra et al., 
2004). 
24. Phenoxodiol and Protopanaxadiol 
Phenoxodiol (2H-1-benzopyran-7-0, 1, 3-[4-
hydroxyphenyl], PXD) is a synthetic analog 
of naturally occurring plant isoflavone, 
genistein. Reports of phenoxodiol 
demonstrated that they inhibit plasma 
membrane electron transport and cell 
proliferation and leads to apoptosis of many 
cancer cell lines. This anti-cancer drug is 
being developed as a “chemosensitizer” and 
is currently under Phase III clinical trials for 
treating ovarian cancer and also in the initial 
stages of clinical trial for treating prostate 
and cervical cancer (Herst et al., 2009). 
Protopanaxadiol (Pandimex™) is a triterpene 
aglycone obtained from saponins of ginseng. 
This compound arrests cell cycle through 
various signaling mechanisms leading to 
cancer cell death. Protopanaxadiol, an 
efficient P-glycoprotein blocker, shows 
cytotoxicity against multi-drug resistant 
tumors. It is used in treating advanced 
cancers of breast, colon-rectum, lung and 
pancreas. Protopanaxadiol is under Phase I 
clinical trial for the treatment of lung cancer 
and solid tumors (Pan et al., 2010). 
25. Perillyl alcohol 
Perillyl alcohol, a monocyclic monoterpene is 
found naturally in many plant species like 
mints, cherries, lavenders, lemongrass, sage, 
cranberries, perilla, wild bergamot, ginger 
grass, savin, caraway and celery seeds. 
Perillyl alcohol induces apoptosis, 
differentiation and cell cycle arrest in the G1 
phase and causes inhibition of cancerous cell 
growth. But the exact mechanism of action is 
yet to be identified. Investigation is still being 
done on the effectiveness of 
chemotherapeutic activity against human 
cancers like non small cell lung cancer, 
prostate cancer and colon cancer. 
Combination therapies were used in treating 
breast cancer cells (Pan et al., 2010; Bardona 
et al., 2002; Yeruva et al., 2007). 
26. Pervilleines 
Pervilleines A, B, C, and F are obtained from 
the roots of Erythroxylum pervillei. They act as 
good inhibitors of P-glycoprotein which 
causes a multidrug resistance related to low 
response for cancer therapy. Further 
investigation on clinical trials is yet to be 
done (Mi et al., 2001; Mi et al., 2002; Mi et al., 
2003). 
27. Salvicine 
Salvicine, a diterpenoid quinone is obtained 
as a derivative of the naturally occurring lead 
saprorthoquinone compound. This lead 
product is isolated from a Chinese medicinal 
plant species, Salvia prionitis Hance 
(Labiatae). Salvicine reported significant in-
vitro and in-vivo activity against malignant 
tumors by inhibiting the activity of 
Topoisomerase II (Deng et al., 2011). 
28. Schischkinnin and Montamine 
Schischkinnin, an indole alkaloid is obtained 
from the seeds of Centaurea schischkinii. They 
showed moderate in-vitro anti-cancer 
activity. Certain flavanoids and lignans were 
also isolated from C. schischkinii which 
exhibited low cytotoxicity. Most of these 
compounds are found effective against colon 
cancer cell lines in-vitro (Shoeb et al., 2005).  
Montamine, a dimeric indole alkaloid is 
obtained from the seeds of Centaurea Montana 
(Asteraceae). Among various compounds 
isolated from C. Montana, montamine 
demonstrated significant in-vitro anti-cancer 
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potential against CaCo2 colon cancer cells 
(Shoeb et al., 2006). 
29. Silvestrol 
Silvestrol, a cytotoxic rocaglate derivative is 
obtained from the fruits and twigs of Aglaia 
foveolata Pannell (Meliaceae). They are found 
effective against prostrate, breast and lung 
cancers. The mechanism of action of 
silvestrol on LNCaP, hormone-dependent 
human prostate cancer cell line was studied. 
It revealed that an apoptosome / 
mitochondrial pathway was involved which 
triggers extrinsic pathway of programmed 
cell death of tumor cells. Another derivative, 
Episilvestrol, an epimer of silvestrol, was 
found less effective as a cytotoxic agent when 
compared to silvestrol (Kinghom et al., 2009; 
Kim et al., 2007). 
30. Triptolide 
Triptolide is a traditional Chinese medicine 
obtained as a purified extract from a shrub-
like vine named Tripterygium wilfordii Hook 
F. This diterpenoid triepoxide enhances the 
anti-tumor effects of cytotoxic and 
chemotherapeutic agents and thereby 
induces apoptosis of tumor cells. Because of 
its severe toxicity and water insolubility, new 
triptolide derivatives like PG490-88 or F60008 
have been synthesized which are water-
soluble and proved to be very safe and 
effective. PG490-88 (14-succinyl triptolide 
sodium salt) is under Phase I clinical trial for 
treatment of prostate cancer (Liu, 2011). 
The semi-synthetic analogs of plant 
derivatives reported by various scientists 
have been compiled and given in Table I. 
Conclusion 
From the preceding review, it can be 
concluded that Etoposide and Teniposide are 
active against lymphomas, bronchial and 
testicular cancer; Topotecan was found active 
against epithelial ovarian cancer and small 
cell lung cancer; Irinotecan was found 
effective against metastatic colorectal cancer; 
Homoharringtonine showed potential 
activity against various leukemic cells; 
Ingenol 3-o-angelate was active against 
actinic keratosis and basal cell carcinoma; 
PG-490-88 was found active against prostate 
cancer; Meisoindigo was effective in patients 
with chronic myeloid leukemia; Berberine 
was active against osteocarcoma, lung, liver, 
prostate and breast cancer; Phenoxodiol was 
found active against ovarian cancer. 
Protopanaxadiol (PandimexTM) was effective 
in treating advanced cancer of the breast, 
colo-rectal, lung and pancreatic cancer. 
Paclitaxel (Taxol®) and docetaxel (Taxotere®) 
was considered to be the most efficient drug 
introduced in the last decade which was 
found active against broad spectrum of 
cancer cells. Hence there is hope in the 
pharmaceutical industry, that even more 
powerful commercial drugs can be 
developed sooner, using plant derivatives, to 
effectively treat cancer and save mankind. 
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